1-5 of 5
residual tumor
Close
Sort by
Journal Articles

MRD in AML: does it already guide therapy decision-making?

Gert Ossenkoppele, Gerrit Jan Schuurhuis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 356–365.
https://doi.org/10.1182/asheducation-2016.1.356
Published: 2016
Journal Articles

Maintenance therapy for multiple myeloma in the era of novel agents

Thierry Facon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 279–285.
https://doi.org/10.1182/asheducation-2015.1.279
Published: 2015
Journal Articles

Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond

Wesam Ahmed, Richard A. Van Etten
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 189–200.
https://doi.org/10.1182/asheducation-2013.1.189
Published: 2013
Journal Articles

Treatment of acute myeloid leukemia: are we making progress?

Alan K. Burnett
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 1–6.
https://doi.org/10.1182/asheducation.V2012.1.1.3797038
Published: 2012
Journal Articles

Current and Investigational Therapies for Patients with CLL

William G. Wierda
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 285–294.
https://doi.org/10.1182/asheducation-2006.1.285
Published: 2006